Unofficial consolidated textConsolidated 2026-01-01English

Regulation (EU) 2017/745

MDR current consolidated text

English consolidated text dated 2026-01-01, reproduced from EUR-Lex. It is not an authentic Official Journal reproduction. It is recommended to check the original source in case of doubt.

This reader URL is available while the local development server is running. It is deliberately omitted from static builds.

Browse the regulation

Contents

Articles124

CHAPTER I

SCOPE AND DEFINITIONS

CHAPTER II

MAKING AVAILABLE ON THE MARKET AND PUTTING INTO SERVICE OF DEVICES, OBLIGATIONS OF ECONOMIC OPERATORS, REPROCESSING, CE MARKING, FREE MOVEMENT

CHAPTER III

IDENTIFICATION AND TRACEABILITY OF DEVICES, REGISTRATION OF DEVICES AND OF ECONOMIC OPERATORS, SUMMARY OF SAFETY AND CLINICAL PERFORMANCE, EUROPEAN DATABASE ON MEDICAL DEVICES

CHAPTER IV

NOTIFIED BODIES

CHAPTER V

CLASSIFICATION AND CONFORMITY ASSESSMENT

  1. Article 51Classification of devices

CHAPTER VI

CLINICAL EVALUATION AND CLINICAL INVESTIGATIONS

  1. Article 61Clinical evaluation
  2. Article 62General requirements regarding clinical investigations conducted to demonstrate conformity of devices
  3. Article 63Informed consent
  4. Article 64Clinical investigations on incapacitated subjects
  5. Article 65Clinical investigations on minors
  6. Article 66Clinical investigations on pregnant or breastfeeding women
  7. Article 67Additional national measures
  8. Article 68Clinical investigations in emergency situations
  9. Article 69Damage compensation
  10. Article 70Application for clinical investigations
  11. Article 71Assessment by Member States
  12. Article 72Conduct of a clinical investigation
  13. Article 73Electronic system on clinical investigations
  14. Article 74Clinical investigations regarding devices bearing the CE marking
  15. Article 75Substantial modifications to clinical investigations
  16. Article 76Corrective measures to be taken by Member States and information exchange between Member States
  17. Article 77Information from the sponsor at the end of a clinical investigation or in the event of a temporary halt or early termination
  18. Article 78Coordinated assessment procedure for clinical investigations
  19. Article 79Review of coordinated assessment procedure
  20. Article 80Recording and reporting of adverse events that occur during clinical investigations
  21. Article 81Implementing acts
  22. Article 82Requirements regarding other clinical investigations

CHAPTER VII

POST-MARKET SURVEILLANCE, VIGILANCE AND MARKET SURVEILLANCE

CHAPTER VIII

COOPERATION BETWEEN MEMBER STATES, MEDICAL DEVICE COORDINATION GROUP, EXPERT LABORATORIES, EXPERT PANELS AND DEVICE REGISTERS

CHAPTER IX

CONFIDENTIALITY, DATA PROTECTION, FUNDING AND PENALTIES

CHAPTER X

FINAL PROVISIONS

Annexes17
  1. Annex IGENERAL SAFETY AND PERFORMANCE REQUIREMENTS
  2. Annex IITECHNICAL DOCUMENTATION
  3. Annex IIITECHNICAL DOCUMENTATION ON POST-MARKET SURVEILLANCE
  4. Annex IVEU DECLARATION OF CONFORMITY
  5. Annex VCE MARKING OF CONFORMITY
  6. Annex VIINFORMATION TO BE SUBMITTED UPON THE REGISTRATION OF DEVICES AND ECONOMIC OPERATORS IN ACCORDANCE WITH ARTICLES 29(4) AND 31, CORE DATA ELEMENTS TO BE PROVIDED TO THE UDI DATABASE TOGETHER WITH THE UDI-DI IN ACCORDANCE WITH ARTICLES 28 AND 29, AND THE UDI SYSTEM
  7. Annex VIIREQUIREMENTS TO BE MET BY NOTIFIED BODIES
  8. Annex VIIICLASSIFICATION RULES
  9. Annex IXCONFORMITY ASSESSMENT BASED ON A QUALITY MANAGEMENT SYSTEM AND ON ASSESSMENT OF TECHNICAL DOCUMENTATION
  10. Annex XCONFORMITY ASSESSMENT BASED ON TYPE-EXAMINATION
  11. Annex XICONFORMITY ASSESSMENT BASED ON PRODUCT CONFORMITY VERIFICATION
  12. Annex XIICERTIFICATES ISSUED BY A NOTIFIED BODY
  13. Annex XIIIPROCEDURE FOR CUSTOM-MADE DEVICES
  14. Annex XIVCLINICAL EVALUATION AND POST-MARKET CLINICAL FOLLOW-UP
  15. Annex XVCLINICAL INVESTIGATIONS
  16. Annex XVILIST OF GROUPS OF PRODUCTS WITHOUT AN INTENDED MEDICAL PURPOSE REFERRED TO IN ARTICLE 1(2)
  17. Annex XVIICORRELATION TABLE